Skip to main content

Table 4 Changes of T category and stage group in 7-TNM and 8-TNM

From: Application of the new 8th TNM staging system for non-small cell lung cancer: treated with curative concurrent chemoradiotherapy

(A) T category

 

8-TNM

Total

T1a

T1b

T1c

T2a

T2b

T3

T4

7-TNM

T1a

2

3

0

0

0

0

0

5 (7.8%)

T1b

0

0

3

4

1

0

0

8 (12.5%)

T2a

0

0

4

3

3

0

0

10 (15.6%)

T2b

0

0

0

0

1

7

0

8 (12.5%)

T3

0

0

1

1

4

5

5

16 (25%)

T4

0

0

0

0

0

2

15

17 (26.6%)

Total

2 (3.1%)

3 (4.7%)

8 (12.5%)

8 (12.5%)

9 (14.1%)

14 (21.9%)

20 (31.3%)

 

(B) Stage group

 

8-TNM

Total

IB

IIB

IIIA

IIIB

IIIC

7-TNM

IB

1

0

0

0

0

1 (1.6%)

IIA

0

1

0

0

0

1 (1.6%)

IIB

0

1

2

0

0

3 (4.7%)

IIIA

0

1

18

10

0

29 (45.3%)

IIIB

0

0

0

22

8

30 (46.9%)

Total

1 (1.6%)

3 (4.7%)

20 (31.3%)

32 (50%)

8 (12.5%)

 
  1. 7-TNM seventh American Joint Committee on Cancer TNM staging system, 8-TNM eighth American Joint Committee on Cancer TNM staging system